Risklick
Bern
About Risklick
Risklick is develops a first-of-the-kind data-driven tool to allow end-users to identify similar Clinical trials(CTs) and assess risks in early steps of the protocol design. CTs are used to determine the efficacy and safety of an experimental treatment; however, up to 90% of them fail in the early stage of protocol design and the nature and complexity of CTs make risk assessment difficult and time-consuming.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Funding stage: Seed
- Last round: Seed (Apr 2024)
- Website: risklick.ch
- Phone: +41 78 781 41 35
Industries & Categories
Biotechnology, Clinical Trials, Software
Social Profiles
Canonical: https://fsome.com/organization/risklick-2245805 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.